Juno Bio logo

Juno Bio

Provides vaginal microbiome testing for women’s health, supporting analysis of microbial profiles linked to gynecological wellness.

Deep Tech
Microbiome Diagnostics
Total Raised
$4M
Last Valuation
$25M
Headquarters
London, United Kingdom

Overview

Juno Bio develops vaginal microbiome testing focused on women’s health, helping characterize microbial profiles relevant to gynecological and reproductive wellness. Its offering targets people and care providers seeking more specialized insight into vaginal health. The company’s differentiation is its focus on a specific, under-served area of microbiome diagnostics rather than broad consumer testing. Ada Ventures and Illumina Accelerator backed a roughly $4M round to help scale its vaginal microbiome testing platform.

Funding History

1 round · Jul 2026
$4M
Total Raised
1
Valuation: $25M
Cumulative: $4M

Ada Ventures and Illumina Accelerator back Juno Bio’s $3.8M round to scale vaginal microbiome testing

Investors not disclosed
Source

Frequently Asked Questions

How much has Juno Bio raised in total?
Juno Bio has raised a total of $4M across 1 funding round.
What does Juno Bio do?
Juno Bio develops vaginal microbiome testing focused on women’s health, helping characterize microbial profiles relevant to gynecological and reproductive wellness. Its offering targets people and care providers seeking more specialized insight into vaginal health. The company’s differentiation is its focus on a specific, under-served area of microbiome diagnostics rather than broad consumer testing. Ada Ventures and Illumina Accelerator backed a roughly $4M round to help scale its vaginal microbiome testing platform.
Where is Juno Bio headquartered?
Juno Bio is headquartered in London, United Kingdom.